Confluence Wealth Services, Inc.
Source: SEC Form 13F · as of Mar 2026Confluence Wealth Services, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $53.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$53.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 42,111 | $10.3M |
| LLYELI LILLY & Co | 11,028 | $10.1M |
| ABBVAbbVie Inc. | 28,030 | $6.1M |
| MRKMerck & Co., Inc. | 44,212 | $5.3M |
| ABTABBOTT LABORATORIES | 35,391 | $3.6M |
| PMPhilip Morris International Inc | 20,388 | $3.4M |
| MCKMcKesson Corporation | 3,056 | $2.6M |
| PFEPFIZER INC | 76,950 | $2.2M |
| AMGNAMGEN INC | 5,661 | $2.0M |
| CAHCardinal Health Inc. | 8,847 | $1.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,482 | $1.8M |
| ZTSZoetis Inc. | 11,417 | $1.3M |
| KRYSKrystal Biotech, Inc. | 2,922 | $755K |
| BMYBRISTOL MYERS SQUIBB CO | 11,192 | $679K |
| GILDGILEAD SCIENCES, INC. | 3,176 | $443K |
| ELVElevance Health Inc. | 1,346 | $394K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 547 | $244K |
| CORCencora Inc. | 651 | $205K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.